EE569 Axicabtagene Ciloleucel for Relapsed/Refractory Diffuse Large B-Cell Lymphoma in the Irish Healthcare Setting: Cost-Utility and Value of Information Analysis
Dec 1, 2022, 00:00
10.1016/j.jval.2022.09.809
https://www.valueinhealthjournal.com/article/S1098-3015(22)03013-3/fulltext
Title :
EE569 Axicabtagene Ciloleucel for Relapsed/Refractory Diffuse Large B-Cell Lymphoma in the Irish Healthcare Setting: Cost-Utility and Value of Information Analysis
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)03013-3&doi=10.1016/j.jval.2022.09.809
First page :
Section Title :
Open access? :
No
Section Order :
10348